The molecular basis of familial hypercholesterolemia in The Netherlands

Abstract. Mutations in the low-density lipoprotein (LDL) receptor gene are responsible for familial hypercholesterolemia (FH). At present, more than 600 mutations in this gene are known to underlie FH. However, the array of mutations varies considerably in different populations. Therefore, the delineation of essentially all LDL-receptor gene mutations in a population is a prerequisite for the implementation of nation-wide genetic testing for FH. In the Netherlands, mutation analysis by denaturing gradient gel electrophoresis and sequencing in 1641 clinically diagnosed FH patients resulted in the characterization of 159 different LDL-receptor gene defects. The nine most common mutations were responsible for 66.5% of our FH index cases. Of these, four mutations occurred with relatively high frequencies in specific parts of the Netherlands. The remaining mutations were only encountered in single FH patients, comprising 22.2% of the patient cohort analyzed. Subsequent genetic testing of relatives of the index cases within the national FH screening program resulted in the identification of 5,531 FH patients in total. The analysis for LDL-receptor mutations is a continuing effort to update the LDL-receptor mutation catalogue. Subsequently, with the newly generated index cases, the screening program can be extended and continued to identify and treat FH patients as early as possible and reduce cardiovascular morbidity and mortality in these patients at high risk.

[1]  K Kontula,et al.  Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  S. Humphries,et al.  Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. , 1999, Journal of lipid research.

[3]  M. Manns,et al.  Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online. , 1999 .

[4]  L. V. Van Gaal,et al.  Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics. , 1994, Atherosclerosis.

[5]  M. Nagano,et al.  Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia , 1999 .

[6]  J. Després,et al.  Identification of three mutations in the low‐density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians , 1998, Human mutation.

[7]  J. Després,et al.  Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men. , 1999, Atherosclerosis.

[8]  S. Humphries,et al.  Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands , 1998, Human Genetics.

[9]  H. Hobbs,et al.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. , 1990, Annual review of genetics.

[10]  S. Tonstad,et al.  Molecular genetics of familial hypercholesterolaemia in Norway , 1997, Journal of internal medicine.

[11]  P. Guldberg,et al.  Clinically applicable mutation screening in familial hypercholesterolemia , 1996, Human mutation.

[12]  M. Hayden,et al.  Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Marais,et al.  Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry , 1999, Clinical genetics.

[14]  M. Hayden,et al.  Detection of the Pro664‐Leu mutation in the low‐density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and Canada , 1992, Clinical genetics.

[15]  Abrahamson,et al.  Mutations in the low‐density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response , 1998, European journal of clinical investigation.

[16]  H. Hobbs,et al.  Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. , 1987, The New England journal of medicine.

[17]  P. Guldberg,et al.  Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B , 1998, Clinical genetics.

[18]  R. Westendorp,et al.  Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. , 2000, Atherosclerosis.

[19]  M. Hayden,et al.  Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[20]  C. Junien,et al.  A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. , 1999, American journal of human genetics.

[21]  S E Humphries,et al.  Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. , 2001, Atherosclerosis.

[22]  I. Young,et al.  Three novel mutations in the EGF precursor homology domain of the low‐density lipoprotein receptor gene in Northern Irish patients with familial hypercholesterolemia , 1995, Human mutation.

[23]  P. Van Acker,et al.  Low‐density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia , 2000, Clinical genetics.

[24]  N. Gregersen,et al.  An alanine29‐serine variant in exon 2 of the low density lipoprotein receptor gene: no association with hypercholesterolemia , 1994, Clinical genetics.

[25]  E. Sijbrands,et al.  Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. , 1995, Journal of lipid research.

[26]  J. Deslypere,et al.  High prevalence of a novel mutation in the exon 4 of the low‐density lipoprotein receptor gene causing familial hypercholesterolemia in Belgium , 1997, Clinical genetics.

[27]  J. Viikari,et al.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene. , 1995, American journal of human genetics.

[28]  M. Ruiz-Galdón,et al.  The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. , 1999, Atherosclerosis.

[29]  D. Rubinsztein,et al.  Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygote. , 1996, Atherosclerosis.

[30]  D. Russell,et al.  The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.

[31]  C. Boileau,et al.  Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia. , 2000, Molecular and cellular probes.

[32]  R. Safadi,et al.  Molecular genetics of familial hypercholesterolemia in Israel , 1996, Human Genetics.

[33]  B. Tomlinson,et al.  Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  L. Havekes,et al.  A novel mutation M‐21V in exon 1 of the low density lipoprotein receptor gene causing familial hypercholesterolemia , 1997, Clinical genetics.

[35]  O. Faergeman,et al.  Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. , 1999, Atherosclerosis.

[36]  M. Arca,et al.  Low density lipoprotein receptor mutations in a selected population of individuals with moderate hypercholesterolemia. , 1998, Atherosclerosis.

[37]  M. Kotze,et al.  The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia. , 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[38]  D. Guernsey,et al.  A novel mutation in Exon 4 of the low density lipoprotein receptor gene resulting in heterozygous familial hypercholesterolemia associated with decreased ligand binding. , 1998, Atherosclerosis.

[39]  T. Foulon,et al.  Identification of a mutation, N543H, in exon 11 of the low‐density lipoprotein receptor gene in a French family with familial hypercholesterolemia , 1995, Human mutation.

[40]  E. Sijbrands,et al.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.

[41]  M. Trip,et al.  Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the Netherlands , 2000, Clinical genetics.

[42]  F. Raal,et al.  CpG hotspot mutations at the LDL receptor locus are a frequent cause of familial hypercholesterolemia among South African Indians , 1997, Clinical Genetics.

[43]  B. Guy-grand,et al.  Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjects. , 1999, Atherosclerosis.

[44]  M. Hayden,et al.  Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia. , 1993, Archives of internal medicine.

[45]  R. Müllenbach,et al.  An efficient salt-chloroform extraction of DNA from blood and tissues. , 1989, Trends in genetics : TIG.

[46]  L. Havekes,et al.  Mutational and genetic origin of LDL receptor gene mutations detected in both Belgian and Dutch familial hypercholesterolemics , 1997, Human Genetics.

[47]  M. Manns,et al.  Mutation analysis in 46 German families with familial hypercholesterolemia: Identification of 8 new mutations , 1999, Human mutation.

[48]  J W Jukema,et al.  The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. , 1998, The New England journal of medicine.

[49]  J J Kastelein,et al.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. , 2001, BMJ : British Medical Journal.

[50]  I. Young,et al.  Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemia. , 1999, Atherosclerosis.

[51]  K. Kontula,et al.  Familial Hypercholes terolemia , 1996 .

[52]  M. Skolnick,et al.  Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[53]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[54]  V. Gudnason,et al.  Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia , 1997, Human mutation.

[55]  I. Rabbone,et al.  Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[56]  W. März,et al.  1.P.257 Mutations in the genes encoding the low-density lipoprotein receptor and apolipoprotein B in Southwest Germany , 1997 .

[57]  J. Boer,et al.  Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle. , 1998, Atherosclerosis.

[58]  R. Frants,et al.  Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolemic patients and the presence of a common 4 kb deletion. , 1990, Atherosclerosis.

[59]  J. Lubiński,et al.  LDL-R and Apo-B-100 gene mutations in Polish familial hypercholesterolemias , 1998, Human Genetics.

[60]  M. Nagano,et al.  Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia. Mutation in brief no. 248. Online. , 1999, Human mutation.

[61]  J. Boer,et al.  Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women , 1999, Clinical genetics.

[62]  A. Soutar,et al.  Expression of an LDL receptor allele with two different mutations (E256K and I402T) , 2000, Molecular pathology : MP.